Integrated Filing — IndAS

General information about company
Scrip Code	517168
NSE Symbol	SUBROS
MSEI Symbol	NOTLISTED
ISIN	INE287B01021
Name of company	SUBROS LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	22-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	16-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Manufacturing of Automotive Air Conditioning System
Start date and time of board meeting	22-May-2025   11:30:00
End date and time of board meeting	22-May-2025   14:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	9084600000	33675700000
	Other income	64600000	207100000
	Total income	9149200000	33882800000
2	Expenses
(a)	Cost of materials consumed	6553500000	24286500000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	49400000	35300000
(d)	Employee benefit expense	803200000	3224500000
(e)	Finance costs	31500000	114800000
(f)	Depreciation, depletion and amortisation expense	342400000	1281700000
(f)	Other Expenses
1	Other Expenses	750900000	2906100000
	Total other expenses	750900000	2906100000
	Total expenses	8530900000	31848900000
3	Total profit before exceptional items and tax	618300000	2033900000
4	Exceptional items	0	0
5	Total profit before tax	618300000	2033900000
6	Tax expense
7	Current tax	181200000	627600000
8	Deferred tax	-24900000	-97000000
9	Total tax expenses	156300000	530600000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	462000000	1503300000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	2000000
16	Total profit (loss) for period	462000000	1505300000
17	Other comprehensive income net of taxes	7000000	-5900000
18	Total Comprehensive Income for the period	469000000	1499400000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	130500000	130500000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		10810800000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	7.08	23.07
	Diluted earnings (loss) per share from continuing operations	7.08	23.07
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	7.08	23.07
	Diluted earnings (loss) per share from continuing and discontinued operations	7.08	23.07
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notes: n n1. The above consolidated financial results were reviewed by the Audit Committee and thereafter approved by the Board of Directors at their respective meetings held on May 22, 2025. n2. The consolidated financial results include the results of the following entities namely, Subros Limited (Company) and Denso Subros Thermal Engineering Centre India Private Limited (Joint Venture). n3. The consolidated financial results has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards IND AS prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. n4. The Company and its joint venture's operations comprise of only one segment i.e. Thermal products. Hence, no further information is required to be given in respect of segment. n5. The Board of directors have recommended a final dividend of Rs. 2.60 per equity share (130% on face value of equity shares of Rs. 2 each) for the year ended March 31, 2025. The dividend is subject to approval of shareholders at the ensuing Annual General Meeting of the Company. n 6. In financial year 2019-20, the tax laws were amended, providing an option to pay tax at 22% plus applicable surcharge and cess (New Rate) effective April 1, 2019, with a condition to surrender specified deductions/incentives. The Company has opted to pay tax at New Rate from FY 2024-25 onwards and measured its tax balances accordingly. tttt n7. Figures for the quarters ended March 31, 2025 and March 31, 2024 represent the difference between the audited figures in respect of full financial years and the published figures for the nine months ended December 31, 2024 and December 31, 2023, respectively which were subjected to limited review. n n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	5555300000
	Capital work-in-progress	499300000
	Investment property	0
	Goodwill	0
	Other intangible assets	1305100000
	Intangible assets under development	287600000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	19500000
	Non-current financial assets
	Non-current investments	289400000
	Trade receivables, non-current	0
	Loans, non-current	1900000
	Other non-current financial assets	123700000
	Total non-current financial assets	415000000
	Deferred tax assets (net)	0
	Other non-current assets	375400000
	Total non-current assets	8457200000
2	Current assets
	Inventories	3738500000
	Current financial asset
	Current investments	854600000
	Trade receivables, current	4513200000
	Cash and cash equivalents	363600000
	Bank balance other than cash and cash equivalents	402100000
	Loans, current	7700000
	Other current financial assets	65300000
	Total current financial assets	6206500000
	Current tax assets (net)	0
	Other current assets	183800000
	Total current assets	10128800000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	18586000000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	130500000
	Other equity	10810800000
	Total equity attributable to owners of parent	10941300000
	Non controlling interest
	Total equity	10941300000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	1000000
	Total non-current financial liabilities	1000000
	Provisions, non-current	170400000
	Deferred tax liabilities (net)	409400000
	Deferred government grants, Non-current	0
	Other non-current liabilities	91100000
	Total non-current liabilities	671900000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	36300000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	5566800000
	Total Trade payable	5603100000
	Other current financial liabilities	803300000
	Total current financial liabilities	6406400000
	Other current liabilities	424700000
	Provisions, current	79700000
	Current tax liabilities (Net)	62000000
	Deferred government grants, Current	0
	Total current liabilities	6972800000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	7644700000
	Total equity and liabilites	18586000000
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block
Textual Information(1)	See accompanying notes to the Consolidated Financial Results

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Gain / (Loss) on remeasurements of post employment benefit obligations	9500000	-7800000
2	Share of other Comprehensive income of Joint Venture accounted for using equity method	-100000	-100000
	Total Amount of items that will not be reclassified to profit and loss	9400000	-7900000
2	Income tax relating to items that will not be reclassified to profit or loss	2400000	-2000000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	7000000	-5900000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			2033900000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			114800000
	Adjustments for decrease (increase) in inventories			11200000
	Adjustments for decrease (increase) in trade receivables, current			-1686400000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			42800000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-3900000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			574300000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			51100000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1281700000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			41700000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			3900000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-17800000
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-4800000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-124400000
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-4500000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			279700000
	Net cash flows from (used in) operations			2313600000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			565300000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1748300000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			100000000
	Other cash payments to acquire equity or debt instruments of other entities			459200000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			15100000
	Purchase of property, plant and equipment			1179300000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			84300000
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			700000
	Interest received			76100000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-283200000
	Net cash flows from (used in) investing activities	-1645500000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			0
	Payments of lease liabilities			4100000
	Dividends paid			117400000
	Interest paid			114700000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			105400000
	Net cash flows from (used in) financing activities			-130800000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-28000000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-28000000
	Cash and cash equivalents cash flow statement at beginning of period			0
	Cash and cash equivalents cash flow statement at end of period			-28000000